LEIDOS BIOMEDICAL RESEARCH INC

Federal contract award, Leidos, $27,524,748

Key CONT_AWD_HHSN26100019_7529_HHSN261201500003I_7529. First seen by this system September 5, 2026 through the historical sweep, new to the watchlist, public 10 days before this system saw it. One version on record.

Cite this row

On this site https://evidence.ourrevolution.media/filings/leidos/CONT_AWD_HHSN26100019_7529_HHSN261201500003I_7529

At the source https://www.usaspending.gov/award/CONT_AWD_HHSN26100019_7529_HHSN261201500003I_7529

Observed 2026-09-05, version 1, retrieved 2026-09-05T00:54:40Z

Content hash 923c39862ceb53e37fa5106edd588da0c1eaeb395c4c12cb745e7db4f15de475

The source record can change after this date; the key, hash and retrieval time name exactly the response this system stored. See license and citation.

Versions

Version	Amount	Change	Occurred	Published	Retrieved	How it arrived	Content hash
1 current	$27,524,748	first version	September 15, 2016	August 26, 2026	2026-09-05T00:54:40Z	historical sweep	`923c39862ceb`

Archived copy

https://web.archive.org/web/20261011060525/https://www.usaspending.gov/award/CONT_AWD_HHSN26100019_7529_HHSN261201500003I_7529 captured by this system, October 11, 2026

What the amount is made of

8 recorded actions, so the amount is the award's current total across all of them. 4 of them obligated money. Measured 2026-10-12, when USAspending reported a total obligation of $27,524,748.

Action date	Modification	Type	Obligated	Description as recorded
August 25, 2026	P00007	FUNDING ONLY ACTION	+$49,826	RESEARCH, DEVELOPMENT, PRODUCTION AND SUPPORT FOR CLINICAL TRIALS BROADLY NEUTRALIZING MONOCLONAL ANTIBODIES (BNMABS)
December 20, 2021	P00006	OTHER ADMINISTRATIVE ACTION	no money	RESEARCH, DEVELOPMENT, PRODUCTION AND SUPPORT FOR CLINICAL TRIALS BROADLY NEUTRALIZING MONOCLONAL ANTIBODIES (BNMABS)
June 10, 2021	P00005	OTHER ADMINISTRATIVE ACTION	no money	RESEARCH, DEVELOPMENT, PRODUCTION AND SUPPORT FOR CLINICAL TRIALS BROADLY NEUTRALIZING MONOCLONAL ANTIBODIES (BNMABS)
March 2, 2021	P00004	OTHER ADMINISTRATIVE ACTION	no money	RESEARCH, DEVELOPMENT, PRODUCTION AND SUPPORT FOR CLINICAL TRIALS BROADLY NEUTRALIZING MONOCLONAL ANTIBODIES (BNMABS)
September 27, 2018	3	OTHER ADMINISTRATIVE ACTION	+$67,104	IGF::OT::IGF RESEARCH, DEVELOPMENT, PRODUCTION AND SUPPORT FOR CLINICAL TRIALS BROADLY NEUTRALIZING MONOCLONAL ANTIBODIES (BNMABS)
August 10, 2017	2	FUNDING ONLY ACTION	+$12,669,444	IGF::OT::IGF RESEARCH, DEVELOPMENT, PRODUCTION AND SUPPORT FOR CLINICAL TRIALS BROADLY NEUTRALIZING MONOCLONAL ANTIBODIES (BNMABS)
January 13, 2017	1	OTHER ADMINISTRATIVE ACTION	no money	IGF::OT::IGF RESEARCH, DEVELOPMENT, PRODUCTION AND SUPPORT FOR CLINICAL TRIALS BROADLY NEUTRALIZING MONOCLONAL ANTIBODIES (BNMABS)
September 15, 2016	base	not on file	+$14,738,374	IGF::OT::IGF RESEARCH, DEVELOPMENT, PRODUCTION AND SUPPORT FOR CLINICAL TRIALS ? BROADLY NEUTRALIZING MONOCLONAL ANTIBODIES (BNMABS)

Last refreshed November 4, 2026 at 2:31 PM UTC.